SCI时时刷

search
Nutrition interventions for youth with dyslipidemia: a National Lipid Association clinical perspective
Available online 30 July 2022Author links open overlay panelLaurenWilliamsMCN, RDN, LDaCarissa M.Baker-SmithMD, MPH, MS FA...
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association
Statin-associated muscle symptoms (SAMS) are the most common form of statin intolerance and are associated with increased ...
Correlation between early changes of serum lipids and clinical severity in patients with wasp stings
Background: Wasp stings are a serious problem worldwide, and patients in severe cases may experience multi-organ failure. ...
Cholesterol Mass Efflux Capacity and Coronary Artery Calcium:  The Multi-Ethnic Study of Atherosclerosis
Available online 14 September 2022Highlights•CMEC quantifies net movement of cholesterol between cells and HDL•We determin...
Monkeypox is a global public health emergency: The role of repurposing cholesterol lowering drugs not to be forgotten
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
Rate of 30-day Readmission & Economic Burden of Patients with Acute Congestive Heart Failure with Co-existing Metabolic Syndrome
Lead Author's Financial DisclosuresNothing to disclose.Background/SynopsisHeart failure (HF) and meta-bolic syndrome (MetS...
Obicetrapib Lowers LDL-C in Patients Taking High Intensity Statins - Results from the ROSE Clinical Trial
Volume 16, Issue 3, Supplement, July–August 2022, Page e73Lead Author's Financial DisclosuresNothing to disclose.Study Fun...
Characterization of Inclisiran Use in Real World: Prescription Data from Germany
Volume 16, Issue 3, Supplement, July–August 2022, Pages e73-e74Lead Author's Financial DisclosuresRaquel Lahoz is an emplo...
Unique Case of Management of Severe Hypertriglyceridemia Secondary to Familial Chylomicronemia Syndrome
ResultsA 61-year-old slightly overweight female with a history of congenital aplasia of the pancreas, coronary artery dise...
Pregnancy-Induced Hypertension: The Potential Role of Cholesterol Crystals in the Maternal Decidua
Volume 16, Issue 3, Supplement, July–August 2022, Page e75Lead Author's Financial DisclosuresQuest Diagnostics.Background/...
The Effect of Estrogen and Testosterone on Cholesterol Crystallization
Volume 16, Issue 3, Supplement, July–August 2022, Pages e75-e76Lead Author's Financial DisclosuresNothing to disclose.Back...
GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis
Available online 6 August 2022Highlights•HTG-AP patients had a higher rate of GPIHBP1 autoantibody than reported HTG patie...
Cost-effectiveness of Population-Wide Genomic Screening for Familial Hypercholesterolemia in the United States
Available online 30 July 2022Highlights•We modeled population genomic FH screening for cost-effectiveness.•Population FH g...
FAMILIAL CHYLOMICRONEMIA SYNDROME. A SIXTY YEAR FOLLOW-UP IN TWO SIBLINGS AND THEIR KINDREDS. NOSOLOGICAL AND CLINICAL CONSIDERATIONS.
Available online 31 July 2022HIGHLIGHTS•Four subjects with familial chylomicronemia syndrome were identified•Sixty-year cl...
Nutrition Interventions for Youth with Dyslipidemia An National Lipid Association Clinical Perspective
Available online 30 July 2022Author links open overlay panelLaurenWilliamsMCN, RDN, LD1Carissa M.Baker-SmithMD, MPH, MS FA...
Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia
BackgroundEvolocumab is a fully human monoclonal antibody inhibitor of PCSK9 approved for lowering low-density lipoprotein...
Familial Hypobetalipoproteinemia Caused by Homozygous Loss-of-function Mutations in PCSK9: A Case Report
Available online 25 July 2022Highlights•We present a case with FHBL caused by homozygous LOF mutations in PCSK9.•A novel m...
Cognitive Function With Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia: Cognitive safety with evolocumab
Background: Evolocumab is a fully human monoclonal antibody inhibitor of PCSK9 approved for lowering low-density lipoprote...